[Stanford Doctor's Technology Entrepreneurship 03]

As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.

"What You'll Hear"

01:00 Applications of AI technology in the pharmaceutical industry and the driving forces behind it

06:10 How to express complex content in a simple way?

08:11 A step in GPT training: transforming structured language into a language that natural language systems can understand

10:12 The future of AI: why programming and model training are so important?

12:12 AI and LIFES: key trends and opportunities for the next decade

14:14 AI and LIFESS: challenges and opportunities, exploring the possibility of human-machine coexistence

18:15 Applications and challenges of AI technology in drug development—Dr. Che Xing's perspectives and insights

"Permanent Hosts"

"Special Guest"

Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.

Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.

Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.

Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.

"Music"

"Find Us Here"